ZEISS Medical Technology announced today the successful early clinical implantations of the ZEISS AT LUCIA toric 721P ...

Intraocular lens (IOL) implantation has become the cornerstone of cataract surgery and the correction of aphakia, with evolving techniques to address cases lacking sufficient capsular support or ...

Johnson & Johnson (NYSE: JNJ) is expanding the U.S. roll-out of its latest advancement in presbyopia-correcting intraocular ...

Children with nontraumatic cataracts undergoing implantation of a secondary intraocular lens (IOL) after lensectomy are at a risk for complications including a diagnosis of glaucoma and visual axis ...

The eye's natural crystalline lens can be replaced with an artificial lens—known as an intraocular lens—to restore clarity and lead to a vast improvement in quality of life for patients with cataracts ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. It also marks part two of ...

Johnson & Johnson expands TECNIS PureSee access, strengthening its eye care portfolio and medical technology growth narrative.

Treatment of glaucoma is directed towards controlling intraocular pressure (IOP) and the options are many, starting from medical therapy to cyclodestructive surgeries. Drainage devices are a treatment ...

ZEISS has announced successful early implantations of its AT LUCIA toric 721P intraocular lens, which combines an aspheric ...

The new intraocular lens combines an aspheric bitoric optic with a patented non-constant aberration design (ZO optic) on a fully preloaded, hydrophobic c-Loop platform to help deliver excellent ...